» Articles » PMID: 26675566

Biomarkers for Physical Frailty and Sarcopenia: State of the Science and Future Developments

Overview
Date 2015 Dec 18
PMID 26675566
Citations 109
Authors
Affiliations
Soon will be listed here.
Abstract

Physical frailty and sarcopenia are two common and largely overlapping geriatric conditions upstream of the disabling cascade. The lack of a unique operational definition for physical frailty and sarcopenia and the complex underlying pathophysiology make the development of biomarkers for these conditions extremely challenging. Indeed, the current definitional ambiguities of physical frailty and sarcopenia, together with their heterogeneous clinical manifestations, impact the accuracy, specificity, and sensitivity of individual biomarkers proposed so far. In this review, the current state of the art in the development of biomarkers for physical frailty and sarcopenia is presented. A novel approach for biomarker identification and validation is also introduced that moves from the 'one fits all' paradigm to a multivariate methodology.

Citing Articles

A Preliminary Screening Tool for High-Risk Frailty in Older Adults Patients with Pulmonary Tuberculosis.

Li H, Zhou Y, Yu H, Jiang J, Cai Y Clin Interv Aging. 2025; 20:57-68.

PMID: 39867857 PMC: 11766138. DOI: 10.2147/CIA.S493887.


Changes in muscle quality and biomarkers of neuromuscular junctions and muscle protein turnover following 12 weeks of resistance training in older men.

Mastalerz A, Hooshmand-Moghadam B, Moazamigoudarzi S, Golestani F, Hooshmand-Moghadam B, Johne M Biol Sport. 2024; 41(4):285-292.

PMID: 39416488 PMC: 11475000. DOI: 10.5114/biolsport.2024.141064.


Association of metabolic syndrome and frailty with postoperative complications in older gastric cancer patients: A body composition perspective.

Jiang X, Ding L, Guo Y, Miao X, Zhao K, Chen L Cancer Med. 2024; 13(18):e70194.

PMID: 39315666 PMC: 11420831. DOI: 10.1002/cam4.70194.


Exploring the metabolomics profile of frailty- a systematic review.

Shekarchian A, Bandarian F, Hadizadeh A, Amirsardari Z, Sharifi Y, Ayati A J Diabetes Metab Disord. 2024; 23(1):289-303.

PMID: 38932837 PMC: 11196473. DOI: 10.1007/s40200-023-01379-y.


Visit-to-visit variability in multiple biological measurements and cognitive performance and risk of cardiovascular disease: A cohort study.

Sherlock L, Lee S, Cukierman-Yaffe T, Leong D, Gerstein H, Bosch J Cereb Circ Cogn Behav. 2024; 6:100223.

PMID: 38800700 PMC: 11127101. DOI: 10.1016/j.cccb.2024.100223.


References
1.
Rantanen T, Guralnik J, Foley D, Masaki K, Leveille S, Curb J . Midlife hand grip strength as a predictor of old age disability. JAMA. 1999; 281(6):558-60. DOI: 10.1001/jama.281.6.558. View

2.
Asea A, Kraeft S, Stevenson M, Chen L, Finberg R, Koo G . HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med. 2000; 6(4):435-42. DOI: 10.1038/74697. View

3.
. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001; 69(3):89-95. DOI: 10.1067/mcp.2001.113989. View

4.
Fried L, Tangen C, Walston J, Newman A, Hirsch C, Gottdiener J . Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56(3):M146-56. DOI: 10.1093/gerona/56.3.m146. View

5.
Visser M, Pahor M, Taaffe D, Goodpaster B, Simonsick E, Newman A . Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci. 2002; 57(5):M326-32. DOI: 10.1093/gerona/57.5.m326. View